Syneos Health Inc. and four former executives must contend with investor allegations the biopharmaceutical solutions company ...

Syneos Health cemented a multi-year deal to use Microsoft’s platform for deploying artificial intelligence (AI) in its clinical trials and commercial programs. The agreement announced this week ...

Syneos Health had been eyeing a sale since March 2020. Apparently, for several years, many of the smaller drugmakers upon which Syneos relied for a big slice of its CRO business had delayed or dropped ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The Triangle is now home to one ...

ClearBridge Investments, an investment management company, released its “ClearBridge Select Strategy” third quarter 2022 investor letter. A copy of the same can be downloaded here. The strategy ...

Syneos Health, Inc. SYNH is well-poised for growth in the coming quarters, backed by strategic partnership deals and contributions from the Syneos One portfolio. The company’s Clinical Solutions arm ...

North Carolina-based contract research organization Syneos Health is making a play to capitalize on China’s rapidly ascendant biopharma industry. Syneos has acquired Chinese CRO Bestudy to secure a ...

Syneos SYNH released its second-quarter results, which included revenue of $1.36 billion, representing a 0.4% increase from the prior-year period. The company continues to face headwinds, including a ...

Syneos Health, a leading biopharmaceutical contract research organization, agreed to be acquired for $7.1 billion by a group of private equity firms. Elliott Investment Management, Patient Square ...

Narrow-moat Syneos SYNH announced it will be acquired by a consortium of three private investment firms (Elliott Investment Management, Patient Square Capital, and Veritas Capital) for $43 per share ...

March 9 (Reuters) - Syneos Health Inc SYNH.O, a U.S. contract research organization (CRO) that serves the pharmaceutical industry, is exploring a sale, people familiar with the matter said on Monday.